Real-World Outcomes Following Asthma Treatment Escalation From Medium-Dose ICS to high-Dose ICS or Biologics
Njira Lugogo, Aakash Bipin Gandhi, Andrew Moraco(Tufts University), Rohit Katial, Natalia Petruski‐Ivleva(AVEO Oncology (United States)), Jason Kwah(Regeneron (United States)), Joe Yang, Hernan Avella, Félix Rondeau, Riley Taiji, Francis Vekeman
Cited by 0
Related Papers
Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
|Journal of Renal Nutrition|2017|254
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
|Annals of the Rheumatic Diseases|2023|95
Depression, Anxiety, and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-Cohort Study
|American Journal of Epidemiology|2020|66